Stryker’s 2018 sales increased 9.3 percent to $413.6 billion, with growth across all lines.
Johnson & Johnson subsidiary DePuy Synthes plans to create 30 new jobs at its Ireland hub because of a $41.16 million investment.
The FDA granted Zimmer Biomet 510(k) clearance for its ROSA Knee System.
Medtronic launched the Mazor X Stealth Edition in the U.S.
SpineGuard released its 2018 full-year financial report.
Globus Medical’s Secure-C Cervical Artificial Disc was granted expanded coverage by Anthem.
A U.S. Court of Appeals for the Federal Circuit affirmed a previous judgment in a patent infringement case that ordered Medtronic to pay millions of dollars to a spine surgeon.
Healthcare technology solutions provider Nextech Systems purchased SRS Health Software.
Aurora Spine received a U.S. patent related to its minimally invasive spine implants.
Johnson & Johnson and DePuy Orthopaedics settled ongoing litigation surrounding allegations the company used deceptive marketing claims for two metal-on-metal implants for $120 million.
The 1,000th patient completed one year of follow-up in X-Bolt Orthopaedics’ World Hip Trauma Evaluation 4 study.
Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.
More articles on devices and implants:
2 Qs with OSSIO CEO Brian Verrier
DePuy Synthes creates new jobs in Ireland with investment: 3 details
Zimmer Biomet receives FDA approval for robotically-assisted knee system: 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
